Moderna AI-assisted personalized mRNA cancer therapy succeeds in Phase 3 trial
kimmonismus · x · 2026-08-19
Moderna and Merck announced positive Phase 3 trial results for intismeran autogene (mRNA-4157) combined with Keytruda, meeting primary endpoints of recurrence-free and distant metastasis-free survival in resected stage IIB-IV melanoma.
Key Technology & Workflow:
- Sequencing & Analysis: Tumor sequencing compared to healthy DNA.
- AI Target Identification: AI helps identify tumor mutations most likely to trigger an immune response.
- Personalized Production: An individualized mRNA treatment encoding up to 34 targets is produced to train the immune system to fight cancer.
More from Apps
- Robinhood's new Platinum card includes $250 annual Waymo ride credit — reed · 2026-10-16
- ChatGPT's missing UTM tags confirmed as a bug, traffic attribution fully restored — lilyraynyc · 2026-10-16
- Tolan hailed as the AI product Steve Jobs would have built, per viral essay — ajaymehta · 2026-10-16
- Design Studio Runs Agentic Workflows on FLORA Canvas, From Prototype to Shipped Site — round · 2026-10-16
- AI agents have a 'normal-people problem': most users won't hand over their lives — examachine · 2026-10-16
- She planned a Napa trip with an AI planner, changed everything last minute — 'at least the car drove itself' — katieruthmishra · 2026-10-16